These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 7708637)

  • 21. Field trial of short course chemotherapy for pulmonary tuberculosis: results at 30 months.
    Kecharananta P; Jittinandana A; Rattarasarn S; Sriyabhaya N
    J Med Assoc Thai; 1985 Jun; 68(6):283-7. PubMed ID: 4056632
    [No Abstract]   [Full Text] [Related]  

  • 22. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent chemotherapy for adults with tuberculosis.
    Am Rev Respir Dis; 1974 Sep; 110(3):374-6. PubMed ID: 4413938
    [No Abstract]   [Full Text] [Related]  

  • 25. [Short-term chemotherapy of pulmonary tuberculosis. Bacteriologic results].
    Boulahbal F; Tazir M; Khaled S; Chaulet P; el Awadi Z
    Arch Inst Pasteur Alger; 1980; 54():162-72. PubMed ID: 6765476
    [No Abstract]   [Full Text] [Related]  

  • 26. [Complex treatment of patients with destructive pulmonary tuberculosis including intramuscular administration of isoniazid].
    Kalankhodzhaev AA; Gamzaeva NF
    Probl Tuberk; 1991; (5):21-2. PubMed ID: 1924235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
    Am Fam Physician; 1993 Sep; 48(4):671-2. PubMed ID: 8397483
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 29. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Short-term chemotherapy of pulmonary tuberculosis without previous treatment (results up to July 20th, 1972)].
    Poppe de Figueiredo F
    Bull Int Union Tuberc; 1973 Jun; 48(0):139-40. PubMed ID: 4793667
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on short-course chemotherapy of tuberculosis. II. Liver function during 6-month chemotherapy of tuberculosis with hydrazide, rifampicin and pyrazinamide].
    Nikodemowicz E; Kamińska M; Caban M; Struzik T
    Pneumonol Pol; 1984 Oct; 52(10):503-12. PubMed ID: 6533580
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of tuberculosis].
    Ben Amar J; Dhahri B; Aouina H; Azzabi S; Baccar MA; El Gharbi L; Bouacha H
    Rev Pneumol Clin; 2015; 71(2-3):122-9. PubMed ID: 25434510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
    Anglaret X; Saba J; Perronne C; Lacassin F; Longuet P; Leport C; Vildé JL
    Tuber Lung Dis; 1994 Oct; 75(5):334-40. PubMed ID: 7841426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?
    Tortajada C; Martínez-Lacasa J; Sánchez F; Jiménez-Fuentes A; De Souza ML; García JF; Martínez JA; Caylà JA;
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):276-81. PubMed ID: 15786890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
    Seung KJ; Gelmanova IE; Peremitin GG; Golubchikova VT; Pavlova VE; Sirotkina OB; Yanova GV; Strelis AK
    Clin Infect Dis; 2004 Nov; 39(9):1321-8. PubMed ID: 15494909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.